“…For example, in rodents, despite their similar inotropic effects, ouabain and bufalin, but not digoxin, significantly shortened action potential duration (Kieval et al ., 1988; Ruch et al ., 2003); The LD 50 of ouabain and digoxin in rats is 14 and 32 mg·kg −1 respectively (Small et al ., 1971; Hovevey‐Sion and Kaplanski, 1979). However, a decrease in serum K + concentration significantly reduced the minimum lethal dose of digoxin but did not affect that of ouabain (Fricke and Klaus, 1981); bufalin produced a significant increase in heart rate (HR) whereas ouabain did not alter it (Pamnani et al ., 1991). Furthermore, digoxin even reduced cardiac rhythm (Segal et al ., 2000); The infusion of ouabain (Manunta et al ., 2000) and bufalin (Pamnani et al ., 1991) for several weeks produced hypertension in rats, whereas, digoxin did not exert such an effect (Huang et al ., 1999) or even caused a reduction in systemic blood pressure (BP) and prevented ouabain‐induced hypertension when given concomitantly (Manunta et al ., 2000).…”